NCT05956704

Brief Summary

In this study, we intend to enroll orthokeratology subjects aged 8-18 years old with binocular myopia up to and including -4.00 D. They were randomly selected to wear both orthokeratology of different designs, one with an aspheric wide inversion zone design in the optical zone and the other with a traditional spherical curved segment design, and to investigate the differences between these two lenses in terms of their effectiveness in myopia retardation, defocus, and aberration.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2020

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2023

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 14, 2023

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 21, 2023

Completed
Last Updated

July 21, 2023

Status Verified

July 1, 2023

Enrollment Period

2.5 years

First QC Date

July 14, 2023

Last Update Submit

July 14, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in axial length

    Axial length was measured with a biometer

    The change of baseline and 1years

Study Arms (3)

Experimental Group

EXPERIMENTAL
Device: Orthokeratology with aspheric wide inversion zone design in the optical zone

Control group

ACTIVE COMPARATOR
Device: Orthokeratology with traditional spherical design in the optical zone

Blank control group

NO INTERVENTION

Interventions

An orthokeratology lens with an altered optical zone design is designed for an aspherical wide inversion arc in the optical zone

Experimental Group

Subjects wore the orthokeratology with traditional spherical design in the optical zone

Control group

Eligibility Criteria

Age8 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • The age is greater than 8 years and less than 18 years
  • The myopia was within -4.00D (including -4.00D), and the astigmatism was within 1.50D (including 1.50D) in both eyes.
  • Be able to complete 12 months of follow-up
  • They were able to understand the purpose of the trial, volunteered to participate, and signed informed consent by the subjects themselves or their legal guardians

You may not qualify if:

  • Patients with systemic diseases causing immunocompromised or affecting orthokeratology
  • There are other eye diseases that affect orthokeratology lens wearing, such as dacryocystitis, blepharitis, various inflammation, glaucoma, etc
  • Abnormal cornea
  • Previous corneal surgery or corneal trauma history
  • Active keratitis (e.g., corneal infection)
  • Patients with best corrected distance visual acuity of less than 5.0
  • Patients with corneal flat curvature lower than 39.00D, or higher than 48.00D
  • Patients with refractive instability
  • Patients with overt strabismus
  • The corneal epithelium showed obvious fluorescent staining, which was not suitable for patients wearing orthokeratology lenses
  • Patients with dry eye are not suitable for orthokeratology
  • Patients with corneal endothelial cell density less than 2000 cells /mm2
  • Patients who had worn rigid contact lenses (including orthokeratology lenses) within the previous 30 days

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tianjin Eye Hospital

Tianjin, 300020, China

Location

MeSH Terms

Conditions

Myopia

Condition Hierarchy (Ancestors)

Refractive ErrorsEye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 14, 2023

First Posted

July 21, 2023

Study Start

December 1, 2020

Primary Completion

June 1, 2023

Study Completion

June 1, 2023

Last Updated

July 21, 2023

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

Locations